These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9771156)

  • 41. A chimera in every sense: standard of care for physicians practicing complementary and alternative medicine.
    Kallmyer JB
    Indiana Health Law Rev; 2005; 2(1):225-65. PubMed ID: 17111504
    [No Abstract]   [Full Text] [Related]  

  • 42. Age-specific patterns of prostate-specific antigen testing among primary care physician visits.
    McNaughton Collins M; Stafford RS; Barry MJ
    J Fam Pract; 2000 Feb; 49(2):169-72. PubMed ID: 10718695
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Screening for prostate cancer: a survey of New Zealand general practitioners.
    Durham J; Low M; McLeod D
    N Z Med J; 2003 Jun; 116(1176):U476. PubMed ID: 12835804
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PSA testing in office-based clinics: are we testing as much as we think?
    González HM; West B; Underwood W
    J Am Coll Surg; 2005 Dec; 201(6):906-12. PubMed ID: 16310694
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prostate-specific antigen and screening for prostate cancer.
    Han M; Gann PH; Catalona WJ
    Med Clin North Am; 2004 Mar; 88(2):245-65, ix. PubMed ID: 15049577
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Practice patterns in screening and management of prostate cancer in elderly men.
    Konety BR; Sharp VJ; Verma M; Williams RD;
    Urology; 2006 Nov; 68(5):1051-6. PubMed ID: 17095076
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PSA screening for asymptomatic prostate cancer: truth in advertising.
    Hahn DL; Roberts RG
    J Fam Pract; 1993 Nov; 37(5):432-6. PubMed ID: 7693858
    [No Abstract]   [Full Text] [Related]  

  • 48. Discussing prostate cancer testing with patients.
    Berentson-Shaw J
    N Z Med J; 2009 Feb; 122(1290):139-40. PubMed ID: 19319181
    [No Abstract]   [Full Text] [Related]  

  • 49. Avoidance of anticipated regret: the ordering of prostate-specific antigen tests.
    Sorum PC; Mullet E; Shim J; Bonnin-Scaon S; Chasseigne G; Cogneau J
    Med Decis Making; 2004; 24(2):149-59. PubMed ID: 15090101
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Practice parameters as a shield against physician liability.
    Kuc GW
    J Contemp Health Law Policy; 1994; 10():439-68. PubMed ID: 10134814
    [No Abstract]   [Full Text] [Related]  

  • 51. [Practice guideline 'Prostate cancer: diagnosis and treatment'].
    de Reijke TM; Battermann JJ; van Moorselaar RJ; de Jong IJ; Visser AP; Burgers JS
    Ned Tijdschr Geneeskd; 2008 Aug; 152(32):1771-5. PubMed ID: 18754308
    [TBL] [Abstract][Full Text] [Related]  

  • 52. To screen or not to screen? Prostate cancer screening: why it's not for every man.
    Lefevre M
    Medscape J Med; 2008; 10(8):181. PubMed ID: 18924633
    [No Abstract]   [Full Text] [Related]  

  • 53. TMA takes aim against deselection.
    Graddy B
    Tex Med; 1994 Feb; 90(2):14-7. PubMed ID: 8165582
    [No Abstract]   [Full Text] [Related]  

  • 54. Screening for prostate cancer: updated experience from the Tyrol study.
    Horninger W; Berger A; Pelzer A; Klocker H; Oberaigner W; Schönitzer D; Severi G; Robertson C; Boyle P; Bartsch G
    Can J Urol; 2005 Feb; 12 Suppl 1():7-13; discussion 92-3. PubMed ID: 15780158
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Unintended consequences of the doctor shopping bill.
    Tenn Med; 2009 Oct; 102(10):9-10. PubMed ID: 19899313
    [No Abstract]   [Full Text] [Related]  

  • 56. Patient education. PSA: pros and cons.
    Gattellari M; Ward JE
    Aust Fam Physician; 2003 Jun; 32(6):429-30. PubMed ID: 12833769
    [No Abstract]   [Full Text] [Related]  

  • 57. [Prostate cancer screening].
    Saksela E
    Duodecim; 1997; 113(9):871. PubMed ID: 11466912
    [No Abstract]   [Full Text] [Related]  

  • 58. Initiation of salvage therapy for prostate cancer.
    Johnstone PA; Booth R; Riffenburgh RH; Amling CL; Kane CJ; Moul JW
    Prostate Cancer Prostatic Dis; 2002; 5(2):136-43. PubMed ID: 12497004
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Casebook: PSA dilemmas.
    Anderson C
    Practitioner; 2000 Sep; 244(1614):739-41, 744, 748. PubMed ID: 11048370
    [No Abstract]   [Full Text] [Related]  

  • 60. Shared decision making for prostate cancer screening: do patients or clinicians have a choice?
    Woolf SH; Krist A
    Arch Intern Med; 2009 Sep; 169(17):1557-9. PubMed ID: 19786673
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.